215-204-7

Applied Filters:

Keyword:'215-204-7'

Showing 1-4 of 4 results for "215-204-7" within Papers

Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy.

Xueshan Xiao et al.

Biochemical and biophysical research communications, 409(2), 181-186 (2011-05-14)

Bietti crystalline corneoretinal dystrophy (BCD, MIM 210370) is a common form of hereditary retinal degeneration in the Chinese population. BCD is caused by CYP4V2 mutations. Understanding the CYP4V2 mutational spectrum and associated phenotypes is of value for clinical practice. In

Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.

Xiang Y Liu et al.

The Biochemical journal, 369(Pt 1), 31-37 (2002-09-14)

The reduced folate carrier (RFC; SLC19A1) is closely related to the thiamine transporter, SLC19A2 (ThTr1). Hydropathy models for these homologous transporters predict up to 12 transmembrane domains (TMDs), with internally oriented N- and C-termini and a large central loop between

Quantitation of the mRNA levels of Epo and EpoR in various tissues in the ovine fetus.

R Bruce David et al.

Molecular and cellular endocrinology, 188(1-2), 207-218 (2002-03-26)

A partial cDNA of the sheep erythropoietin receptor (EpoR) was obtained and used in real-time PCR to quantitate mRNA levels in placenta, liver and kidney throughout development (term=150 days). This was compared with Epo mRNA levels in the same tissues.

Time course of iron metabolism in critically ill patients.

M Piagnerelli et al.

Acta clinica Belgica, 68(1), 22-27 (2013-05-01)

Altered iron metabolism plays a central role in the development of anaemia in critically ill patients but the time course of iron status in septic and non-septic critically ill patients has not been well defined. Prospective study in a 34-bed

Page 1 of 1